CA2408387A1 - A ligand for enhancing oral and cns delivery of biological agents - Google Patents

A ligand for enhancing oral and cns delivery of biological agents Download PDF

Info

Publication number
CA2408387A1
CA2408387A1 CA002408387A CA2408387A CA2408387A1 CA 2408387 A1 CA2408387 A1 CA 2408387A1 CA 002408387 A CA002408387 A CA 002408387A CA 2408387 A CA2408387 A CA 2408387A CA 2408387 A1 CA2408387 A1 CA 2408387A1
Authority
CA
Canada
Prior art keywords
polypeptide
derivative
amino acid
peptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002408387A
Other languages
English (en)
French (fr)
Inventor
Lioudmila Tchistiakova
Shengmin Li
Grzegorz Pietrzynski
Valery Alakhov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supratek Pharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2408387A1 publication Critical patent/CA2408387A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA002408387A 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents Abandoned CA2408387A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/000926 WO2001090139A2 (en) 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents

Publications (1)

Publication Number Publication Date
CA2408387A1 true CA2408387A1 (en) 2001-11-29

Family

ID=11004110

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002408387A Abandoned CA2408387A1 (en) 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents

Country Status (5)

Country Link
EP (1) EP1385873A2 (de)
JP (1) JP2004514410A (de)
AU (1) AU2001260526A1 (de)
CA (1) CA2408387A1 (de)
WO (1) WO2001090139A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
FR2830016B1 (fr) * 2001-09-27 2004-06-25 Synt Em Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau
PL1877099T3 (pl) 2005-04-06 2013-02-28 Genzyme Corp Terapeutyczne koniugaty zawierające enzym lizosomalny, kwas polisialowy i grupę kierującą
ES2744574T3 (es) 2007-01-18 2020-02-25 Genzyme Corp Oligosacáridos que comprenden un grupo aminooxi y conjugados de los mismos
BR122020010601B8 (pt) 2008-12-16 2021-07-27 Genzyme Corp conjugados de proteína-oligossacarídeo, seus usos, e composições farmacêuticas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599303A3 (de) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide-Konjugate
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain

Also Published As

Publication number Publication date
EP1385873A2 (de) 2004-02-04
JP2004514410A (ja) 2004-05-20
WO2001090139A3 (en) 2002-06-20
WO2001090139A2 (en) 2001-11-29
AU2001260526A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
US7112654B2 (en) Ligand for vascular endothelial growth factor receptor
US6696274B2 (en) Ligand for enhancing oral and CNS delivery of biological agents
JP4320054B2 (ja) ポリヌクレオチド送達のための組成物および方法
US11304991B2 (en) Antimicrobial compositions and methods of use thereof
US20040014652A1 (en) Tumor activated prodrug compounds and methods of making and using the same
EP1286700A2 (de) Krebs aktivierte prodrugverbindungen
KR20030025901A (ko) 염증성 반응 억제용 세포 투과성 펩티드 및 사용방법
KR101898502B1 (ko) 인슐린-유사 성장 인자 1 수용체 결합 펩티드
CA2408387A1 (en) A ligand for enhancing oral and cns delivery of biological agents
US20040102606A1 (en) Histone H2A -derived peptides useful in gene delivery
JP2006516546A (ja) 間質性膀胱炎の治療用細胞調節性ペプチド
JP2004514410A5 (de)
CN112543807B (zh) 片段化的grs多肽、其变体及其应用
US20050277575A1 (en) Therapeutic compositions and methods for treating diseases that involve angiogenesis
CA2408103A1 (en) Tumor activated prodrug compounds and methods of making and using the same
CA2531228A1 (en) Novel therapeutic fusion proteins
WO2005009457A1 (en) Rdp58 compositions and methods for inhibiting vascularization of cell populations
CA2399566A1 (en) Par4 peptides and polypeptides
Bowerman et al. Aromatic Versus Hydrophobic Contributions to Amyloid Peptide Self-Assembly
CA2345214A1 (en) Tissue binding peptides, identification, production and utilization thereof
JP2008505846A (ja) 悪性哺乳動物細胞および形質転換哺乳動物細胞に対して選択的に致死性を有するペプチド

Legal Events

Date Code Title Description
FZDE Dead